PPH
VanEck Pharmaceutical ETF
3월 13일 4:00 PM ET (한국 3/14 05:00)
$104.36
-0.32 ▼ -0.31%
🌙 3월 13일 5:09 PM ET (한국 3/14 06:09)
$104.85
+0.49 ▲ +0.47%
| Index | - | P/E | - | EPS (ttm) | - | Insider Own | - | Shs Outstand | - | Perf Week | -1.49% |
| Market Cap | - | Forward P/E | - | EPS next Y | - | Insider Trans | - | Shs Float | - | Perf Month | -5.38% |
| Enterprise Value | - | PEG | - | EPS next Q | - | Inst Own | - | Short Float | - | Perf Quarter | 5.16% |
| Income | - | P/S | - | EPS this Y | - | Inst Trans | - | Short Ratio | 6.36 | Perf Half Y | 15.8% |
| Sales | - | P/B | - | EPS next 5Y | - | ROA | - | Short Interest | 2.66M | Perf YTD | 1.15% |
| Book/sh | - | P/C | - | EPS past 3/5Y | - | ROE | - | 52W High | -7.3% ($112.58) | Perf Year | 13.94% |
| Cash/sh | - | P/FCF | - | Sales past 3/5Y | - | ROIC | - | 52W Low | 34.36% ($77.67) | Perf 3Y | 41.64% |
| Dividend Est. | $1.83 (1.76%) | EV/EBITDA | - | EPS Y/Y TTM | - | Gross Margin | - | Volatility(W/M) | 1.42% 1.34% | Perf 5Y | 51.57% |
| Dividend TTM | 1.83 | EV/Sales | - | Sales Y/Y TTM | - | Oper. Margin | - | ATR (14) | 1.71 | Perf 10Y | 73.56% |
| Dividend Ex-Date | 2025/12/29 | Quick Ratio | - | EPS Q/Q | - | Profit Margin | - | RSI (14) | 35.7 | Recom | - |
| Dividend Gr. 3/5Y | 15.11% 10.7% | Current Ratio | - | Sales Q/Q | - | SMA20 | -4.13% ($108.86) | Beta | 0.5 | Target Price | - |
| Payout | - | Debt/Eq | - | Earnings | - | SMA50 | -2.9% ($107.48) | Rel Volume | 2.64 | Prev Close | $104.68 |
| Employees | - | LT Debt/Eq | - | EPS/Sales Surpr. | - | SMA200 | 9.05% ($95.7) | Avg Volume(3M) | 0.42M | Price | $104.36 |
| IPO | 2011/12/21 | Option/Short | Yes/Yes | Trades | 3626 | Volume | 1,105,457 | Change | -0.31% |
뉴스 로딩 중...